These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 28850705)
1. Possible Strategies to Make Warfarin Dosing Algorithm Prediction More Accurately in Patients With Extreme Dose. Yan H; Yin JY; Zhang W; Li X Clin Pharmacol Ther; 2018 Feb; 103(2):184. PubMed ID: 28850705 [No Abstract] [Full Text] [Related]
2. Development and Comparison of Warfarin Dosing Algorithms in Stroke Patients. Cho SM; Lee KY; Choi JR; Lee KA Yonsei Med J; 2016 May; 57(3):635-40. PubMed ID: 26996562 [TBL] [Abstract][Full Text] [Related]
3. Development and comparison of a warfarin-dosing algorithm for Korean patients with atrial fibrillation. Cho HJ; On YK; Bang OY; Kim JW; Huh W; Ko JW; Kim JS; Lee SY Clin Ther; 2011 Oct; 33(10):1371-80. PubMed ID: 21981797 [TBL] [Abstract][Full Text] [Related]
5. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic. Shaw PB; Donovan JL; Tran MT; Lemon SC; Burgwinkle P; Gore J J Thromb Thrombolysis; 2010 Aug; 30(2):220-5. PubMed ID: 20204461 [TBL] [Abstract][Full Text] [Related]
6. Warfarin-dosing algorithm based on a population pharmacokinetic/pharmacodynamic model combined with Bayesian forecasting. Sasaki T; Tabuchi H; Higuchi S; Ieiri I Pharmacogenomics; 2009 Aug; 10(8):1257-66. PubMed ID: 19663670 [TBL] [Abstract][Full Text] [Related]
7. Methods for Predicting Warfarin Dose Requirements. Saffian SM; Wright DF; Roberts RL; Duffull SB Ther Drug Monit; 2015 Aug; 37(4):531-8. PubMed ID: 25549208 [TBL] [Abstract][Full Text] [Related]
8. Genotype-guided vs clinical dosing of warfarin and its analogues: meta-analysis of randomized clinical trials. Stergiopoulos K; Brown DL JAMA Intern Med; 2014 Aug; 174(8):1330-8. PubMed ID: 24935087 [TBL] [Abstract][Full Text] [Related]
9. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen. Sconce EA; Kamali F Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764 [TBL] [Abstract][Full Text] [Related]
10. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II). Anderson JL; Horne BD; Stevens SM; Woller SC; Samuelson KM; Mansfield JW; Robinson M; Barton S; Brunisholz K; Mower CP; Huntinghouse JA; Rollo JS; Siler D; Bair TL; Knight S; Muhlestein JB; Carlquist JF Circulation; 2012 Apr; 125(16):1997-2005. PubMed ID: 22431865 [TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of VKORC1 (G-1639A and C1173T) and CYP2C9*3 among patients on warfarin. Teh LK; Langmia IM; Fazleen Haslinda MH; Ngow HA; Roziah MJ; Harun R; Zakaria ZA; Salleh MZ J Clin Pharm Ther; 2012 Apr; 37(2):232-6. PubMed ID: 21507031 [TBL] [Abstract][Full Text] [Related]
12. Genetic testing for warfarin dosing? Not yet ready for prime time. Bussey HI; Wittkowsky AK; Hylek EM; Walker MB Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960 [No Abstract] [Full Text] [Related]
18. Prediction of sensitivity to warfarin based on VKORC1 and CYP2C9 polymorphisms in patients from different places in Colombia. Cifuentes RA; Murillo-Rojas J; Avella-Vargas E Biomedica; 2016 Mar; 36(1):91-100. PubMed ID: 27622442 [TBL] [Abstract][Full Text] [Related]
19. Use of genetic and nongenetic factors in warfarin dosing algorithms. Wu AH Pharmacogenomics; 2007 Jul; 8(7):851-61. PubMed ID: 18240910 [TBL] [Abstract][Full Text] [Related]
20. [Possible application of pharmacogenomics to warfarin therapy]. Murata M Rinsho Byori; 2011 Jun; 59(6):594-7. PubMed ID: 21815482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]